Ads
related to: Enbrel- Safety & Side Effect Info
Get Side Effect Info & Speak With A
Doctor Before Starting Treatment.
- Watch An Injection Video
Some Patients May Use Prefilled
Syringes. Get Self-Injection Info.
- Access Indication Info
Find Out What BIMZELX® Treats And
Learn More About The Condition.
- View Clinical Results
Understand Treatment Effectiveness
& Learn About Patient Experiences.
- Safety & Side Effect Info
Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
The hell of drug pricing boards
Maryland Matters via Yahoo News· 2 days agoJames K. Glassman, the well-known economist whose clients have included pharmaceutical companies, makes the case against prescription drug affordability boards. The post The hell of drug pricing boards appeared first on Maryland Matters.
Understanding State Prescription Drug Affordability Board Landscape in Three Infographics | JD Supra
JD Supra· 4 days agoSeveral states are considering or have enacted legislation to create prescription drug affordability boards (PDABs). PDABs powers vary by state. Colorado’s PDAB—the first in the country to begin ...
Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection?
Forbes· 3 days agoFirstly, let us look at Amgen’s stock performance. AMGN stock has shown gains of 30% from levels of...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 4 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Dorothy Sanders Stratford
Billings Gazette· 6 days agoOur dear friend, Dorothy Sanders Stratford, passed away peacefully the evening of April 14, 2024, at Billings Clinic.
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
Biogen (NASDAQ:BIIB) Given New $342.00 Price Target at HSBC
ETF DAILY NEWS· 4 days agoBiogen (NASDAQ:BIIB – Free Report) had its price objective boosted by HSBC from $339.00 to $342.00 in a research note published on Friday morning, Benzinga reports. BTIG Research restated a ...
Check Out What Whales Are Doing With AMGN - Amgen (NASDAQ:AMGN)
Benzinga· 5 days agoFlagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced ...